CN112206304A - Susceptible constitution conditioning composition and preparation method thereof - Google Patents
Susceptible constitution conditioning composition and preparation method thereof Download PDFInfo
- Publication number
- CN112206304A CN112206304A CN202011138408.7A CN202011138408A CN112206304A CN 112206304 A CN112206304 A CN 112206304A CN 202011138408 A CN202011138408 A CN 202011138408A CN 112206304 A CN112206304 A CN 112206304A
- Authority
- CN
- China
- Prior art keywords
- parts
- susceptible
- conditioning composition
- constitution
- susceptible constitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 17
- 235000008397 ginger Nutrition 0.000 claims abstract description 17
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 241000132012 Atractylodes Species 0.000 claims abstract description 13
- 241001116477 Adenophora triphylla Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 235000004347 Perilla Nutrition 0.000 claims abstract description 10
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 10
- 235000006533 astragalus Nutrition 0.000 claims abstract description 9
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 7
- 240000003870 Ageratum houstonianum Species 0.000 claims abstract description 4
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 20
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 16
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 9
- 241000202726 Bupleurum Species 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 244000274050 Platycodon grandiflorum Species 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 241000213006 Angelica dahurica Species 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 206010035664 Pneumonia Diseases 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 description 19
- 240000003582 Platycodon grandiflorus Species 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 15
- 241000234314 Zingiber Species 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 238000005728 strengthening Methods 0.000 description 11
- 230000036528 appetite Effects 0.000 description 10
- 235000019789 appetite Nutrition 0.000 description 10
- 208000019116 sleep disease Diseases 0.000 description 10
- 208000020685 sleep-wake disease Diseases 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010061428 decreased appetite Diseases 0.000 description 7
- 206010008479 Chest Pain Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 240000004510 Agastache rugosa Species 0.000 description 4
- 208000006083 Hypokinesia Diseases 0.000 description 4
- 235000006751 Platycodon Nutrition 0.000 description 4
- 241001180876 Saposhnikovia Species 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 229930189914 platycodon Natural products 0.000 description 4
- 241001529821 Agastache Species 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 3
- 241000675108 Citrus tangerina Species 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010024642 Listless Diseases 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 229940107666 astragalus root Drugs 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000017971 listlessness Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000019633 pungent taste Nutrition 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 241000208173 Apiaceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000092665 Atractylodes macrocephala Species 0.000 description 2
- 241001660870 Cyrtomium Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 235000001188 Peltandra virginica Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical group CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 244000236521 Bupleurum rotundifolium Species 0.000 description 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241001162994 Rugosus Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and particularly discloses a susceptible constitution conditioning composition which comprises the following raw materials in parts by weight: 9-30 parts of adenophora tetraphylla, 10-35 parts of astragalus membranaceus, 9-28 parts of fried bighead atractylodes rhizome, 1-5 parts of liquorice, 5-18 parts of ginger, 5-10 parts of ageratum, 9-15 parts of poria cocos, 5-10 parts of dried orange peel and 5-10 parts of perilla leaf. The invention also provides a preparation method of the susceptible constitution conditioning composition. The susceptible constitution conditioning composition provided by the invention has the effects of expelling wind, removing cold, removing dampness and enhancing physical strength, and has a good effect of preventing new crown pneumonia.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a susceptible constitution conditioning composition and a preparation method thereof.
Background
The sudden new coronary pneumonia has strong infectivity and high pathogenic rate, and no specific medicine can treat the new coronary pneumonia at present. Under such large circumstances, prevention is an important part of epidemic prevention and control strategies.
The history of traditional Chinese medicine for preventing infectious diseases is long, and the record of the classic traditional Chinese medicine book Huangdi's internal classic: if the healthy qi is not infected with each other, the pathogenic qi cannot be dried, and the pathogenic qi is kept away, i.e., the body's healthy qi needs to be kept away from the pathogenic qi to resist the exogenous pathogenic qi. Therefore, there is a need to develop a Chinese medicinal composition with high safety, significant efficacy, low side effects, low treatment cost, and effective prevention of new coronavirus.
The application publication number CN111603504A of the Chinese invention discloses a Chinese medicinal composition for preventing new crown pneumonia, which comprises 8-18g of raw astragalus root, 8-18g of fried bighead atractylodes rhizome, 8-15g of divaricate saposhnikovia root, 8-15g of mulberry leaf, 8-15g of wrinkled gianthyssop herb, 5-10g of platycodon root, 8-15g of cyrtomium rhizome and 3-6g of raw liquorice. In the patent, the astragalus root has the functions of tonifying qi, invigorating yang, strengthening the exterior and suppressing sweating; the divaricate saposhnikovia root has the effects of dispelling wind, relieving exterior syndrome, eliminating dampness and relieving spasm; the mulberry leaves, the agastache rugosus and the platycodon grandiflorum play roles in dispelling wind and heat, relieving exterior syndrome and eliminating dampness; the platycodon root plays a role in ventilating the lung and eliminating phlegm; the cyrtomium rhizome has the function of killing insects; the mulberry leaf, the platycodon root and the raw liquorice have the effects of clearing lung and relieving sore throat, and are decocted for oral administration or carried with people by using granules.
Although the above patent can play a better role in preventing, the above patent has a poor effect in conditioning listlessness, fatigue, weakness, appetite reduction and sleep disorder of people with susceptible constitution. In essence, the susceptible constitution group is the key group for epidemic prevention and control. The susceptible constitution people refer to people with low immunity, and are very easy to cause bacterial, viral and fungal infection in daily life. The most direct manifestations of susceptible people are easy illness, usually accompanied by constitutional debility, malnutrition, listlessness, fatigue, weakness, appetite decrease, sleep disorder, etc.
In addition, the traditional Chinese medicine composition provided by the patent is mainly used for clinical treatment, is not used for prevention of both medicine and food, and cannot be used for daily conditioning of susceptible people.
Disclosure of Invention
The invention aims to provide a composition which can be used as both medicine and food, has the effects of expelling wind, removing cold and removing dampness, enhancing the physical strength of people with susceptible constitution, strengthening spleen and stomach and improving the appetite of people with susceptible constitution, and a preparation method thereof.
In order to achieve the purpose, the invention provides a susceptible constitution conditioning composition, which comprises the following raw materials in parts by weight: 9-30 parts of adenophora tetraphylla, 10-35 parts of astragalus membranaceus, 9-28 parts of fried bighead atractylodes rhizome, 1-5 parts of liquorice, 5-18 parts of ginger, 5-10 parts of ageratum, 9-15 parts of poria cocos, 5-10 parts of dried orange peel and 5-10 parts of perilla leaf.
The invention also provides a preparation method of the susceptible constitution conditioning composition, which comprises the following steps: the method comprises the following steps: weighing the raw materials according to a certain proportion, adding water, decocting to prepare oral liquid, or spraying and solidifying the water decoction to obtain instant granules.
The invention also provides a preparation method of another susceptible constitution conditioning composition, which is prepared into a medicine bag for use, or is soaked in edible alcohol for 11-15 days, filtered to obtain medicinal liquor, packaged and stored for use as a bath.
The principle and the beneficial effects of the technical scheme are as follows:
on one hand, the susceptible constitution conditioning composition provided by the invention is used for conditioning the susceptible constitution from the aspects of dispelling wind, dispelling cold and removing dampness, and the specific principle is as follows: the new coronary pneumonia belongs to cold-dampness plague in traditional Chinese medicine, has the characteristics of cold evil and dampness evil, and preferably selects traditional Chinese medicine with warm property.
The principle of the susceptible constitution conditioning composition for expelling wind, removing cold and removing dampness provided by the invention is as follows: A. radix astragali, fried rhizoma atractylodis macrocephalae and ginger in a specific proportion are taken as main materials, so as to strengthen the exterior and tonify the lung qi; B. the adenophora tetraphylla, the fried bighead atractylodes rhizome, the poria cocos and the liquorice in a specific proportion have the effects of tonifying spleen and lung and strengthening body resistance; C. and herba Agastaches, folium Perillae, pericarpium Citri Tangerinae and Glycyrrhrizae radix at a certain ratio for eliminating pathogenic factor.
Secondly, the susceptible constitution conditioning composition provided by the invention mainly starts from enhancing physical strength and strengthening spleen and stomach, and is supplemented with eliminating evil and relieving cough to condition susceptible constitution groups for the following reasons:
compared with the population with normal immunity, the susceptible constitution population is more worried about the illness, and the mind is more panic, so that the establishment of the confidence of the susceptible constitution population is more important, and the illness is often represented by shortness of breath, hypodynamia, poor appetite and loose stool as the initial expression, so that the susceptible constitution conditioning composition provided by the invention is mainly started from the aspect of enhancing the physical strength, enhances the physical strength of the susceptible constitution population, is supplemented with the functions of strengthening the spleen and invigorating the stomach, and enhances the gastrointestinal tract digestive ability of the susceptible constitution population, thereby remarkably reducing the fear of the susceptible constitution population and helping the establishment of the confidence of the defeating epidemic situation.
The adenophora tetraphylla, the astragalus membranaceus, the fried bighead atractylodes rhizome, the liquorice and the ginger in the susceptible constitution conditioning composition in a specific proportion mainly play a role in enhancing physical strength, and 5-10 parts of wrinkled gianthyssop herb, 9-15 parts of poria cocos and 5-10 parts of dried orange peel in a specific proportion are supplemented to play a role in strengthening the spleen and stomach.
Thirdly, the fried bighead atractylodes rhizome, the poria cocos and the liquorice in the susceptible constitution conditioning composition provided by the invention also have the effects of strengthening spleen, tonifying qi, eliminating dampness, promoting diuresis, promoting sleep and conditioning qi and blood.
Fourthly, the perilla leaf, the adenophora tetraphylla, the ginger and the liquorice in the specific proportion in the susceptible constitution conditioning composition provided by the invention also have the effects of warming the lung, relieving cough and detoxifying.
Fifthly, the wrinkled gianthyssop herb, the perilla leaf, the dried orange peel and the liquorice in a specific proportion in the susceptible constitution conditioning composition provided by the invention can also be used as an evil dispelling agent, and the effects of aromatic diaphoresis, cold dispelling and dampness resolving are achieved, and cold evil is treated and enters the interior to attack the stomach.
Sixthly, all the raw materials of the susceptible constitution conditioning composition provided by the invention basically belong to medicinal and edible Chinese herbal medicines.
Compared with the existing composition added with the divaricate saposhnikovia root, the invention adopts the ginger to replace the non-medicinal and edible divaricate saposhnikovia root, and the health care requirement of the people with the susceptible constitution is better met.
Preferably, the invention also provides a susceptible constitution conditioning composition, which also comprises 3-10 parts of platycodon grandiflorum.
Preferably, the susceptible constitution conditioning composition also provided by the invention further comprises 6-15 parts of bupleurum.
Preferably, the invention also provides a susceptible constitution conditioning composition, which further comprises 5-8 parts of angelica dahurica.
Preferably, the invention also provides a susceptible constitution conditioning composition, which also comprises 10 to 32 parts of cassia twig.
The raw materials used in the invention are detailed as follows:
the astragalus root used in the invention is the root of leguminous plant astragalus mongholicus and astragalus membranaceus, has sweet taste and mild nature, and enters spleen and lung channels.
The fried bighead atractylodes rhizome used in the invention is a perennial herb of Atractylodes of Compositae, bitter, sweet and warm.
The ginger used in the invention is fresh rhizome of Zingiber officinale Roscoe of Zingiberaceae, has pungent taste and mild nature, and enters lung, spleen and stomach meridians.
The wrinkled gianthyssop herb used in the invention is the overground part of the cablin potchouli herb which is a herbal plant in the family of labiate, has pungent taste and warm nature, and enters spleen, stomach and lung meridians.
The perilla leaf used in the invention is the stem and leaf of perilla leaf of Labiatae, and the perilla belongs to annual herbaceous plants, is warm in nature and pungent in taste, and enters lung and spleen channels. Each 100 g of tender stem and leaf contains 23mg of ferrum, 3.0mg of calcium, 44mg of phosphorus, 9.09mg of carotene, 10.02mg of vitamin B, 20.35mg of vitamin B, 47mg of vitamin C and 1.3mg of nicotinic acid. The seed contains 25% protein and contains various amino acids.
The adenophora tetraphylla used in the invention is dry root of adenophora tetraphylla of Campanulaceae, has sweet taste and slightly cold property, and enters lung and stomach channels.
The tuckahoe used in the invention is dry sclerotium of tuckahoe which is a fungus of Polyporaceae, has sweet and light taste and neutral nature, and enters heart, lung, spleen and kidney meridians.
The tangerine peel used in the invention is mature peel of Rutaceae plant tangerine and its cultivar, and has pungent, bitter and warm properties. It enters spleen and lung meridians.
The liquorice used in the invention is the dried root and rhizome of the liquorice of leguminous plants, has sweet taste and mild nature, and enters heart, lung, spleen and stomach channels.
The platycodon grandiflorum used in the invention is the dried root of platycodon grandiflorum of the family platycodon, is a Chinese medicinal material used as both medicine and food, and is bitter, pungent and mild; entering lung meridian, it has the actions of dispersing lung qi, relieving sore throat, eliminating phlegm and discharging pus. Can be used for treating cough with excessive phlegm, chest distress, pharyngalgia, hoarseness, etc. The production place of the platycodon grandiflorum adopted by the invention is preferably the old soil village in Chongqing Wanzhou area.
The bupleurum used by the invention is the dried root of bupleurum or bupleurum stenophyllum of Umbelliferae, and has the efficacies of tonifying liver and kidney, soothing liver and benefiting gallbladder. Bitter, pungent and slightly cold; it enters liver and gallbladder meridians.
The radix bupleuri used in the invention is the root of angelica dahurica of Umbelliferae, and has warm nature and pungent taste.
The cassia twig used in the invention is pungent, sweet and warm in nature, enters lung, heart and bladder channels, is a commonly used interior-warming medicine for mainly treating interior cold, has the effects of tonifying primordial yang, promoting blood circulation and warming spleen and stomach, and is often combined with liver and kidney tonifying medicines and qi and blood tonifying medicines to condition kidney yang deficiency, decline of vital gate fire and slight cold limbs and pulse.
Detailed Description
The following is further detailed by way of specific embodiments:
example 1
The embodiment provides a susceptible constitution conditioning composition, which comprises the following raw materials in parts by weight: 15 parts of astragalus membranaceus, 15 parts of fried bighead atractylodes rhizome, 10 parts of ginger, 10 parts of ageratum, 10 parts of perilla leaf, 15 parts of adenophora tetraphylla, 15 parts of poria cocos, 10 parts of dried orange peel and 5 parts of liquorice.
The preparation method of the susceptible constitution conditioning composition comprises the following steps: weighing the raw materials according to a certain proportion, decocting together, and finally adding water to decoct together to prepare oral liquid (the weight part of the added water is 1.2 times of the weight part of all the raw materials and the dosage is 600ml per day), or spraying and solidifying the water decoction to prepare instant granules; the oral liquid is taken by 100 ml per day and 300ml per day, and the oral liquid is preferably taken by 200ml per day in the embodiment.
The above composition can be used as medicated bag.
The above composition can also be soaked in edible alcohol for 11-15 days, filtered to obtain medicated liquor, packaged and stored, and used as bath.
Examples 2 to 11
Examples 2-5 differ from example 1 only in that: the weight parts of the raw materials of the examples 2 to 5 are different from those of the example 1;
example 6 differs from example 1 only in that: example 6 further comprises 8 parts of platycodon grandiflorum; the platycodon grandiflorum of example 6 is south platycodon grandiflorum, and the origin is old soil village in Chongqing Wanzhou region;
example 7 differs from example 2 only in that: example 7 also includes 8 parts of bupleurum;
example 8 differs from example 3 only in that: embodiment 8 further comprises 12 parts of radix angelicae;
example 9 differs from example 4 only in that: example 9 further comprises 12 parts of cassia twig;
example 10 differs from example 5 only in that: embodiment 10 also includes 8 parts of platycodon grandiflorum, 8 parts of radix bupleuri, 12 parts of radix angelicae and 12 parts of cassia twig.
Example 10 differs from example 11 only in that: the platycodon grandiflorum of example 10 is south platycodon grandiflorum, the origin is Chongqing Fengjie, the platycodon grandiflorum of example 10 is south platycodon grandiflorum, and the origin is Chongqing Wanzhou old soil village.
Specific starting materials for examples 1-11 are shown in the following table:
comparative examples 1 to 4
Comparative example 1 differs from example 1 only in that: comparative example 1 no astragalus, roasted atractylodes and ginger were added;
comparative example 2 differs from example 2 only in that: comparative example 2 no parched Atractylodis rhizoma, radix Adenophorae, Poria and Glycyrrhrizae radix were added;
comparative example 3 differs from example 2 only in that: comparative example 3 no pericarpium Citri Reticulatae, radix Glycyrrhizae, herba Pogostemonis, and folium Perillae were added;
comparative example 4 differs from example 11 only in that: comparative example 4 no ginger, bupleurum and cassia twig were added;
the compositions of comparative examples 1-4 specifically included the following raw materials as shown in the table:
experiment one
(1) Preparing oral liquid
The oral liquid prepared from the susceptible constitution composition of example 1-9 is administered once a day, 200ml each time, during the period of 1 month and 25 days in 2020 to 3 months and 14 days in 2020.
(2) Experimental methods
In the experiment, the low-immunity workers with symptoms of weak constitution, malnutrition, reduced appetite, listlessness, fatigue, easy fatigue and sleep disorder are selected as the experimental objects, the number of the finally determined susceptible persons is 1500, the susceptible persons are divided into 15 groups, and the specific grouping conditions are shown in the following table:
(3) adverse reaction
After the medicine is taken, no side effect exists, and no abnormality exists in the liver and kidney function physical examination.
(4) Results of the experiment
From the above table it can be derived:
(1) the experimental group 11 (oral liquid prepared in comparative example 1) lacks the astragalus, the fried atractylodes macrocephala koidz and the ginger which have the effects of strengthening the exterior and tonifying lung qi compared with the experimental group 1 (oral liquid prepared in oral example 1), but the experimental group 11 has poor effects of conditioning the weak constitution, fatigue, weakness, fatigue, chest distress, cough and abdominal distension, and also has poor effects of conditioning the inappetence, the sleep disorder, the poor appetite and the loose stool, and proves that the astragalus, the fried atractylodes macrocephala koidz and the ginger in the experimental group 1 have the synergistic effects of conditioning the inappetence, the sleep disorder and the poor appetite and the loose stool with other raw materials.
(2) The experimental group 12 (oral administration of the oral liquid prepared in comparative example 2) did not contain the parched white atractylodes rhizome, adenophora tetraphylla, poria cocos and licorice, which have the effects of strengthening the spleen, strengthening the lung and strengthening the body resistance, compared with the experimental group 2 (oral administration of the oral liquid prepared in example 2), but the experimental group 12 had poor effects of conditioning physical weakness, fatigue, chest distress, cough and abdominal distension, and also had poor effects of conditioning inappetence, sleep disorder, anorexia and loose stool, and it was proved that the parched white atractylodes rhizome, adenophora tetraphylla, poria cocos and licorice in the experimental group 2 also have synergistic effects of anorexia, sleep disorder and loose stool with the remaining raw materials.
(3) Compared with the experimental group 13 (oral liquid prepared by the comparative example 3), the experimental group 2 (oral liquid prepared by the example 2) does not add tangerine peel, liquorice, agastache and perilla leaf which have the function of eliminating evil, and compared with the experimental group 2, the experimental group 13 has long effect time on conditioning the weak constitution, fatigue and weakness, easy fatigue, chest distress, cough and abdominal distension, appetite reduction, sleep disorder and poor appetite and loose stool.
(4) The probability of alleviation is better in experimental group 15 (oral liquid prepared in example 11) and the effect is surprisingly faster in experimental group 1-experimental group 10, compared with experimental group 15.
Compared with the experimental group 15, the experimental group 10 and the experimental group 15 adopt the balloonflower root (experimental group 15) of Chongqing Wanzhou to treat complexionWhite, sallow complexion, low voice and short breath, and hypodynamia.
(5) The experimental group 15 (oral liquid prepared in oral example 11) did not add the function of conditioning the complexion of the people with susceptible constitution compared with the experimental group 14 (oral liquid prepared in comparative example 4)Compared with the experimental group 15, the experimental group 14 recuperates the complexion except for the sallow complexion, the low voice and the weak qi and the shortness of breath of the ginger, the Chinese thorowax root and the cassia twigThe pale and sallow complexion, low voice and weak qi, and poor effect of qi shortness and hypodynamia, which indicates that ginger, Bupleurum root, cinnamon twig and other herbsThe rest raw materials have the synergistic effect of conditioning physical weakness, fatigue, weakness, easy fatigue, chest distress, cough, abdominal distension, inappetence, sleep disorder, poor appetite and loose stool.
(6) Compared with the experimental group 6 (the oral liquid prepared in the example 6), the experimental group 15 (the oral liquid prepared in the oral example 11) does not add radix bupleuri, radix angelicae dahuricae and cassia twig, and the experimental group 15 has the effects of conditioning weak constitution, fatigue and weakness, fatigue, chest distress, cough, abdominal distension, inappetence, sleep disorder and complexionThe relieving probability of white, sallow complexion, low voice and shortness of breath and hypodynamia is higher, and the miraculous effect is quicker.
Experiment two
The oral liquids prepared in examples 1 to 11 were dispensed to 326 patients suspected of new coronary pneumonia, all lung ventilation and air exchange functions were conditioned after taking the oral liquids, symptoms disappeared, and all tests were negative.
The foregoing detailed description of the preferred embodiments of the invention has been presented. It should be understood that numerous modifications and variations could be devised by those skilled in the art in light of the present teachings without departing from the inventive concepts. Therefore, the technical solutions available to those skilled in the art through logic analysis, reasoning and limited experiments based on the prior art according to the concept of the present invention should be within the scope of protection defined by the claims.
Claims (9)
1. A susceptible constitution conditioning composition is characterized by comprising the following raw materials in parts by weight: 9-30 parts of adenophora tetraphylla, 10-35 parts of astragalus membranaceus, 9-28 parts of fried bighead atractylodes rhizome, 1-5 parts of liquorice, 5-18 parts of ginger, 5-10 parts of ageratum, 9-15 parts of poria cocos, 5-10 parts of dried orange peel and 5-10 parts of perilla leaf.
2. The susceptible body conditioning composition of claim 1, further comprising 3-10 parts of Platycodon grandiflorum.
3. The susceptible constitution conditioning composition according to claim 1 or 2, further comprising 6-15 parts of bupleurum.
4. The susceptible constitution conditioning composition according to claim 1 or 2, further comprising 5-8 parts of angelica dahurica.
5. The susceptible body conditioning composition of claim 3, further comprising 5-8 parts of radix Angelicae Dahuricae.
6. The susceptible body conditioning composition of claim 1, 2 or 5, further comprising 10-32 parts of cassia twig.
7. The susceptible body conditioning composition of claim 3, further comprising 10-32 parts of cinnamon twig.
8. A method of preparing a susceptible body conditioning composition according to any one of claims 1 to 7 comprising the steps of: weighing the raw materials according to a certain proportion, adding water, decocting to prepare oral liquid, or spraying the water decoction to solidify into instant granules.
9. The method for preparing a susceptible constitution conditioning composition according to any one of claims 1 to 7, wherein the composition is formulated into a medicated bag for use, or is soaked in edible alcohol for 11 to 15 days, filtered to obtain medicated wine, packaged and stored, and used as a bath.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011138408.7A CN112206304A (en) | 2020-10-22 | 2020-10-22 | Susceptible constitution conditioning composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011138408.7A CN112206304A (en) | 2020-10-22 | 2020-10-22 | Susceptible constitution conditioning composition and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112206304A true CN112206304A (en) | 2021-01-12 |
Family
ID=74054799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011138408.7A Pending CN112206304A (en) | 2020-10-22 | 2020-10-22 | Susceptible constitution conditioning composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112206304A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112915187A (en) * | 2021-02-26 | 2021-06-08 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition capable of dispelling cold and removing dampness, preparation method and application |
CN114601896A (en) * | 2022-03-23 | 2022-06-10 | 陈姜志 | Traditional Chinese medicine composition and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111437355A (en) * | 2020-04-20 | 2020-07-24 | 北京中一堂医疗科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
-
2020
- 2020-10-22 CN CN202011138408.7A patent/CN112206304A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111437355A (en) * | 2020-04-20 | 2020-07-24 | 北京中一堂医疗科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
朱运贵等: ""新冠肺炎诊疗方案治疗药物信息汇编(第一版)"", 《中南药学》 * |
金琪等: ""黄芪于新型冠状病毒肺炎防治应用探讨"", 《辽宁中医药大学学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112915187A (en) * | 2021-02-26 | 2021-06-08 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition capable of dispelling cold and removing dampness, preparation method and application |
CN112915187B (en) * | 2021-02-26 | 2022-07-19 | 江苏康缘药业股份有限公司 | Traditional Chinese medicine composition capable of dispelling cold and removing dampness, preparation method and application |
CN114601896A (en) * | 2022-03-23 | 2022-06-10 | 陈姜志 | Traditional Chinese medicine composition and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102846866B (en) | Chinese medicine composition for prevention and control of porcine circovirus disease and preparation method thereof | |
CN102755619A (en) | Traditional Chinese medicine health care product for treating chronic bronchitis | |
CN111481593A (en) | Traditional Chinese medicine composition and application thereof | |
CN112206304A (en) | Susceptible constitution conditioning composition and preparation method thereof | |
CN102526677A (en) | Chinese medicine foot-massage composition for treating common cold due to wind-cold | |
CN104840935A (en) | Traditional Chinese medicine patch for preventing piglet diarrhea as well as preparation method and application thereof | |
CN104873926A (en) | Traditional Chinese medicine preparation for treating diarrhea as well as preparation method and application of traditional Chinese medicine preparation | |
CN101229337A (en) | Chinese traditional medicine for treating bronchitis and bronchial asthma | |
CN102908425A (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
CN105663360A (en) | Traditional Chinese medicine composition for treating wind-cold type common cold | |
CN105831751A (en) | Health-care traditional Chinese medicine composition with effects of tonifying qi and strengthening brain and preparation method and using method thereof | |
CN104491083A (en) | Medicinal bath preparation for treating pet skin diseases and preparation method of medicinal bath preparation | |
CN104524535B (en) | It is a kind of to treat Chinese medicine composition of chronic cor pulmonale and preparation method thereof | |
CN112691168B (en) | Traditional Chinese medicine composition for preventing and treating nuclear radiation injury and preparation method thereof | |
CN104069421A (en) | Traditional Chinese medicine composition for treating heart diseases | |
CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
CN108619274B (en) | Traditional Chinese medicine composition for treating recurrent respiratory tract infection of children | |
CN101116697A (en) | Chinese traditional medicine composition for treating deficiency-cold type purpura | |
CN104491331B (en) | A kind of pharmaceutical composition with antitussive action | |
CN117883521A (en) | Composition for treating senile constipation and preparation method thereof | |
CN116585382A (en) | Rehabilitation traditional Chinese medicine preparation beneficial to virus infection pneumonia | |
CN115645457A (en) | Traditional Chinese medicine composition for preventing and treating epidemic disease virus and preparation method thereof | |
CN102188573B (en) | Chinese medicinal composition for treating bronchial asthma | |
CN100415256C (en) | Chinese traditional medicine preparation for treating uremia | |
CN113797307A (en) | Traditional Chinese medicine preparation for chronic gastroenteritis, preparation method and taking method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |